Expertise
in drug
reformulation,
delivery and
development

Executive Management

John Devane Ph.D
Executive director & chief executive officer

Mary Martin Ph.D
Executive director & chief operating officer

David Kelly BA, FCA
Executive director & chief financial officer

Patrick Ashe BSc, MBA
Executive director & senior vice president, business development